Doctis

Decision on Optimal Combinatorial Therapies in IMIDs using Systems approaches

[Doctis @DoctisEU]

🧪 As part of the #DocTISProject series, we feature Edgar Angelats, Postdoctoral Scientist at @idibaps.

🔬His work focuses on the #preclinical validation of combinatorial therapies identified through #SystemsBiology approaches for #IMIDs.

📖 https://t.co/c58LCODIg3

#IMID

[Doctis @DoctisEU]

🧪 On #ClinicalTrialsDay, we highlight this #DocTISProject publication in #Rheumatology Advances in Practice by @cardiffuni & @VHIR_.

📢 An innovative #ClinicalTrial protocol exploring combinatorial therapies for #IMIDs.

👉 https://t.co/RY2NEsRrvd

#IMIDResearch #EUResearch

[Doctis @DoctisEU]

📢 In this new #DocTISProject interview, Stefania Madonna from @idi_irccs and collaborator of @UniVerona shares her perspective on patient stratification, #Psoriasis research and the future of #Dermatology and #ClinicalResearch.

👉 https://t.co/WvZbi1Um02

#Dermatology #IMIDs

[Doctis @DoctisEU]

📢 In this #DocTISProject interview, María López Lasanta (@vallhebron, @VHIR_) shares how her work helps understand treatment response in #IMIDs.

📖 https://t.co/A3aVDpZYx9

#PersonalisedMedicine #Rheumatology #ClinicalResearch #IMID #AutoimmuneTherapies #IMIDResearch

[Doctis @DoctisEU]

📍 Last week, the @RheumatologyUK conference brought together leading experts in #Rheumatology.

👥 @ErnestChoy1 (@cardiffuni) convened a #DocTISProject investigators meeting to review progress of the #ClinicalTrial.

👉 https://t.co/Cotwvlce50

#BSR26 #IMID #IMIDs #IMIDResearch

[Doctis @DoctisEU]

📰 New #DocTISProject study in Rheumatology Advances in Practice, journal of @RheumatologyUK, published by @OxUniPress.

📢 Protocol of a #ClinicalTrial on combinatorial therapies for #IMIDs, work by @cardiffuni & @VHIR_.

👉 https://t.co/RY2NEsRrvd

#Rheumatology #IMIDResearch

[Doctis @DoctisEU]

📢 As part of the #DocTISProject series, we feature Adrià Aterido, computational biologist at @VHIR_.

🧬 His work uses #MultiOmics and #SystemsBiology to uncover disease mechanisms and support therapies for #IMIDs.

👉 https://t.co/beRjPvABme

#DataDrivenMedicine #IMID

[Doctis @DoctisEU]

📊 Turning data into better treatment decisions

🔬 Sergio Martínez (@IMIDomics) shares how data analysis helps understand patient responses and identify effective drug combinations in #IMIDs.

🔎 https://t.co/F3W5QjLo9U

#DataScience #DocTISProject #IMIDResearch #EUResearch

[Doctis @DoctisEU]

🩺 On #WorldHealthDay 2026, @WHO highlights how science drives global health

🔬 Progress depends on cooperation across researchers, clinicians & institutions. #DocTISProject applies this approach to advance treatments for #IMIDs

👉 https://t.co/zKhNMznxaM

#TogetherForScience

[Doctis @DoctisEU]

👩‍🔬 Get to know the people behind #DocTISProject!

🔬 Nerea Clemente, from @zabala_eu, shares how research moves beyond the lab to real-world application.

🔎 https://t.co/T5QIWW7Lev

#InnovationWorks #ZabalaInnovation #DocTISProject #IMID #IMIDs #AutoimmuneTherapies #EUResearch

[Doctis @DoctisEU]

👩‍🔬 Meet the people behind #DocTISProject!

🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses.

🔎 https://t.co/MIhk2ju3uo

#IMID #IMIDs #EUResearch

[Doctis @DoctisEU]

🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026.

🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies.

🌐 https://t.co/zKhNMznxaM

#IMID

[Doctis @DoctisEU]

🧬 What is #DocTISProject?

🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way.

🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments.

🔎 Learn more: https://t.co/zKhNMznxaM

#IMIDResearch

[Doctis @DoctisEU]

🩺 #UlcerativeColitis is a chronic immune-mediated inflammatory disease (#IMID) that impacts patients’ quality of life.

🧬 At #DocTISProject, we advance #IMIDResearch to improve therapeutic strategies and patient outcomes.

🔎 Learn more: https://t.co/AurQGG8smh

#EUResearch

[Doctis @DoctisEU]

📣 Dr @hoheyn (@cnag_eu) presented research using data generated within #DocTISProject at the “Single cell-omics and the Human Cell Atlas” event, organised by @FundacionAreces and @SpringerNature.

👉 More: https://t.co/wCreZSvr5N

#SingleCellOmics #HumanCellAtlas #IMIDResearch

[Doctis @DoctisEU]

🧬 On #RareDiseaseDay, taking place tomorrow, #DocTISProject supports @eurordis and reaffirms its commitment to advancing research to address unmet medical needs and ensure no patient is left behind.

🔎 Learn more: https://t.co/nFjmjX8OLN

#IMID #IMIDs #AutoimmuneTherapies

[Doctis @DoctisEU]

📺 Watch the full webinar here: https://t.co/n7IZo5WlU2

@VHIR_ | @cardiffuni | @UniVerona | @ChariteBerlin | @cnag_eu | @idibaps | @hudsonalpha | @IMIDomics | @zabala_eu

#AutoimmuneTherapies #IMIDResearch #HealthcareInnovation

[Doctis @DoctisEU]

💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration.

📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients.

#IMID

[Doctis @DoctisEU]

The study led by @cnag_eu and published in @NatureMedicine, which uses data from the #DocTISProject and maps cellular inflammation at an unprecedented scale, has been featured on one of Spain’s main national TV channels.

More info:👉 https://t.co/Wiq4qdH7eW

#SingleCell #IMIDs

[CNAG @cnag_eu]

🙌¡Nuestro atlas de la inflamación, de nuevo en TV!
Un grupo de investigadores de CNAG publican el 1º atlas celular de la inflamación, que ha servido para desarrollar una herramienta IA para mejorar el diagnóstico de pacientes

📺Fuente: @A3Noticias
🔗https://t.co/EYogFI5Fcx

[Doctis @DoctisEU]

🔬 #DocTISProject data featured in @NatureMedicine!

🧬 DocTIS contributed to a @cnag_eu-led study on cellular inflammation, developed by @hoheyn, @jc_nietos, @ljimenezgracia, @DMasper0, @saguilarfer, @fcraighero and collaborators.

🔗 https://t.co/Wiq4qdGzpo

#NatureMedicine